# Advances in understanding and treating disorders of consciousness caused by brainstem injury

**Authors:** Qiheng He, Sipeng Zhu, Xiaoke Chai, Tianqing Cao, Nan Wang, Yi Yang

PMC · DOI: 10.1186/s41016-025-00411-9 · Chinese Neurosurgical Journal · 2025-10-20

## TL;DR

This review explores how brainstem injuries cause disorders of consciousness and highlights new insights into mechanisms and potential treatments.

## Contribution

The paper synthesizes recent findings on brainstem mechanisms and therapies for disorders of consciousness.

## Key findings

- Brainstem nuclei and neurotransmitters like serotonin and norepinephrine are critical for arousal and consciousness.
- Disrupted connectivity between the ARAS and cortical networks correlates with consciousness impairment severity.
- Pharmacological and neuromodulation therapies show potential for restoring consciousness in affected patients.

## Abstract

Disorders of consciousness (DoC) present significant challenges in clinical neurology, particularly when caused by brainstem injury. The brainstem’s role, especially its ascending reticular activating system (ARAS), is crucial for maintaining arousal, a fundamental component of consciousness. However, the precise mechanisms by which brainstem injuries lead to DoC remain incompletely understood, and treatment options are limited. This gap in understanding hampers the development of effective therapies and impedes clinical management of these conditions. Here, we provide a comprehensive review of the latest research on the anatomical, neurochemical, and network-based mechanisms linking brainstem injury to DoC. We focus on the brainstem nuclei and neurotransmitter systems, such as serotonin from the dorsal raphe nucleus, norepinephrine from the locus coeruleus, and dopamine from the ventral tegmental area, highlighting their roles in arousal regulation and brainstem–cortical communication. Furthermore, we explore how disruptions in connectivity between the ARAS and cortical networks, as revealed by advanced neuroimaging techniques like diffusion tensor imaging and functional MRI, correlate with the severity of consciousness impairment. Additionally, we discuss therapeutic strategies, including pharmacological interventions and neuromodulation techniques, which aim to restore consciousness by targeting these disrupted networks. This review advances the field by synthesizing current knowledge on the brainstem’s role in consciousness and highlighting the potential of targeted therapies to improve patient outcomes. By elucidating the mechanisms underlying DoC caused by brainstem injury, this review provides a foundation for future research to develop more effective treatments, ultimately contributing to better clinical management and recovery strategies for patients with DoC.

## Linked entities

- **Chemicals:** serotonin (PubChem CID 5202), norepinephrine (PubChem CID 951), dopamine (PubChem CID 681)

## Full-text entities

- **Diseases:** brainstem injuries (MESH:D020295), Disorders of consciousness (MESH:D003244)
- **Chemicals:** serotonin (MESH:D012701), dopamine (MESH:D004298), norepinephrine (MESH:D009638)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12536528/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12536528/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12536528/full.md

---
Source: https://tomesphere.com/paper/PMC12536528